Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct;130(10):605-611.
doi: 10.1111/apm.13261. Epub 2022 Jul 25.

Vaginal microbiome following orally administered probiotic

Affiliations
Free PMC article

Vaginal microbiome following orally administered probiotic

Frederik Boetius Hertz et al. APMIS. 2022 Oct.
Free PMC article

Abstract

Here, we present a longitudinal shotgun sequencing metagenomics study of 16 healthy, Danish women in the reproductive age. The aim of the study was to investigate whether lactobacilli, orally consumed, had any impact on the vaginal microbiome and its functional potential. The 16 women aged 19-45 years were recruited from Copenhagen, Denmark. One baseline vaginal sample (Day 0) and two study samples (Days 25-30 and Days 55-60, respectively), were sampled. The vaginal samples were analyzed by shotgun metagenomics. We detected 26 species in the vaginal microbiota of the 16 women, of which six belonged to the Lactobacillus genus. We observed three vaginal microbiome clusters mainly dominated by Gardnerella vaginalis, Lactobacillus iners, or Lactobacillus crispatus. The oral probiotic had no detectable effect on either the composition or the functional potential of the vaginal microbiota. Most of the study subjects (11 out of 16 women) exhibited only minor changes in the vaginal microbiome during the treatment with probiotics. Any compositional changes could not be associated to the probiotic treatment. Future studies may benefit from an increased number of participants, and administration of the probiotics during conditions with bacterial imbalance (e.g., during/after antibiotic treatment) or the use of different Lactobacillus spp. known to colonize the vagina.

Keywords: Vaginal microbiome; healthy microbiome; public health; shotgun metagenomics; women.

PubMed Disclaimer

Conflict of interest statement

FBH and NFM are medical doctors employed by the public health care system in Denmark. FBH and NFM declare no support from any organization for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous three years, no other relationships or activities that could appear to have influenced the submitted work. LSM and EB are employed by Deerland Probiotics and Enzymes A/S a commercial company producing and selling probiotics, including probiotics containing Lactobacillus spp. Deerland Probiotics & Enzymes A/S had no role in conducting the study, analysis or interpretation the data. JBH and AP are employed by Clinical Microbiomics, a private company. Clinical Microbiomics have been involved in the study to ensure correct microbiological analyses. Clinical Microbiomics have had no influence on the purpose.

Figures

Fig. 1
Fig. 1
MGS abundance profiles of the top‐10 most dominant MGSs in the study vaginal samples. The samples are clustered based on Bray–Curtis dissimilarity and a phylogenetic tree on top of the plot exhibits the different species clusters. Bars do not sum to 100% because we represent only the 10 most dominant species across samples, and because some reads mapped to non‐MGS‐annotated genes.
Fig. 2
Fig. 2
Vaginal samples. PCoA based on Bray–Curtis dissimilarities between vaginal samples calculated using the MGS abundances in vaginal samples. Numbers denote the subject, and the samples are color coded by visit. The median, of all the samples per visit, is expressed with a larger dot (centroid).

Similar articles

Cited by

References

    1. Keith JW, Pamer EG. Enlisting commensal microbes to resist antibiotic‐ resistant pathogens. J Exp Med. 2019;216(1):10–19. 10.1084/jem.20180399 - DOI - PMC - PubMed
    1. Smith SB, Ravel J. The vaginal microbiota, host defence and reproductive physiology. J Physiol. 2017;595(2):451–63. - PMC - PubMed
    1. MacIntyre DA, Chandiramani M, Lee YS, Kindinger L, Smith A, Angelopoulos N, et al. The vaginal microbiome during pregnancy and the postpartum period in a European population. Sci Rep. 2015;5:1–9. - PMC - PubMed
    1. Falagas ME, Betsi GI, Athanasiou S. Probiotics for the treatment of women with bacterial vaginosis. Clin Microbiol Infect. 2007;13(7):657–64. - PubMed
    1. Larsson P‐G, Brandsborg E, Forsum U, Pendharkar S, Andersen K, Nasic S, et al. Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses. BMC Infect Dis. 2011;11(1):223. - PMC - PubMed